[Thiazides--a first choice against high blood pressure].
Thiazide therapy of hypertension has increased substantially in Norway during the last decade. This is caused partly by changed dosage recommendations - which has led to fewer side effects - and an increased awareness of the cost associated with hypertension therapy. Thiazide therapy is among one of the most cost-effective drug therapies within preventive cardiology. Prevention of primary endpoints such as cerebrovascular disease, cardiovascular mortality and congestive heart failure is well documented.
Meland
Eivind
E
Institutt for samfunnsmedisinske fag, Universitetet i Bergen, Kalfarveien 31, 5018 Bergen, Norway. eivind.meland@isf.uib.no
D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D003362:Cost-Benefit Analysis; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D049971:Thiazides / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D049971:Thiazides